Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Oct 11, 2022	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000315066-22-001787.pdf
Oct 07, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000080.pdf 0001883850-22-000080.xls
Oct 07, 2022	CORRESP	CORRESP	View HTML 0001104659-22-107078.pdf
Oct 05, 2022	3	Initial filing by director officer or owner of more than ten percent.	View HTML 0001104659-22-106300.pdf 0001104659-22-106300.xls
Oct 05, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000076.pdf 0001883850-22-000076.xls
Oct 05, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000077.pdf 0001883850-22-000077.xls
Oct 05, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000078.pdf 0001883850-22-000078.xls
Oct 05, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001104659-22-106311.pdf 0001104659-22-106311.xls
Oct 03, 2022	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-22-104901.pdf 0001104659-22-104901.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Oct 03, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000072.pdf 0001883850-22-000072.xls

Data provided by Kaleidoscope.

Investors & Media